Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kalbitor – Treatment for Hereditary Angioedema

Drug (brand/generic)

Kalbitor / Ecallantide

Company

Dyax Corp

Product description

Human plasma kallikrein inhibitor

Current indication

Hereditary angioedema

Market sector

Haematology

Development status

Approved in the US
Expand
Close
Close
Close

Go Top